Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice. [electronic resource]
Producer: 20160725Description: e0148255 p. digitalISSN:- 1932-6203
- Animals
- Antithrombin III -- pharmacology
- Blood Coagulation -- drug effects
- Blood Coagulation Tests
- Coagulants -- pharmacology
- Disease Models, Animal
- Enzyme Activation -- physiology
- Factor IX -- genetics
- Factor VIIa -- pharmacology
- Factor XIa -- pharmacology
- Half-Life
- Hemophilia B -- drug therapy
- Hemorrhage -- drug therapy
- Immunoglobulin Fc Fragments -- genetics
- Mice
- Mice, Inbred C57BL
- Recombinant Fusion Proteins -- genetics
- Thrombin -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.